These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 9447215)
21. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke. Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445 [TBL] [Abstract][Full Text] [Related]
22. Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1. Lambrew CT; Bowlby LJ; Rogers WJ; Chandra NC; Weaver WD Arch Intern Med; 1997 Dec 8-22; 157(22):2577-82. PubMed ID: 9531226 [TBL] [Abstract][Full Text] [Related]
23. Why are eligible thrombolysis candidates left untreated? Hills NK; Johnston SC Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S210-6. PubMed ID: 17178305 [TBL] [Abstract][Full Text] [Related]
24. [Intravenous thrombolytic therapy: ideal treatment for acute ischemic stroke]. Kappelle LJ; van der Worp HB Ned Tijdschr Geneeskd; 2000 May; 144(22):1025-8. PubMed ID: 10850102 [TBL] [Abstract][Full Text] [Related]
25. Pre- and in-hospital intersection of stroke care. Meretoja A; Kaste M Ann N Y Acad Sci; 2012 Sep; 1268():145-51. PubMed ID: 22994234 [TBL] [Abstract][Full Text] [Related]
26. Virtual TeleStroke support for the emergency department evaluation of acute stroke. Schwamm LH; Rosenthal ES; Hirshberg A; Schaefer PW; Little EA; Kvedar JC; Petkovska I; Koroshetz WJ; Levine SR Acad Emerg Med; 2004 Nov; 11(11):1193-7. PubMed ID: 15528584 [TBL] [Abstract][Full Text] [Related]
27. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152 [TBL] [Abstract][Full Text] [Related]
28. Administration of tissue plasminogen activator for acute ischemic stroke in a rural Wisconsin hospital. Charipar R; Charipar E WMJ; 2008 Jul; 107(4):176-80. PubMed ID: 18702433 [TBL] [Abstract][Full Text] [Related]
29. Identification of nonischemic stroke mimics among 411 code strokes at the University of California, San Diego, Stroke Center. Hemmen TM; Meyer BC; McClean TL; Lyden PD J Stroke Cerebrovasc Dis; 2008; 17(1):23-5. PubMed ID: 18190817 [TBL] [Abstract][Full Text] [Related]
36. Thrombolytic therapy as early management of ischemic stroke. Killeen I Am Fam Physician; 1998 Jan; 57(1):24-6, 28-30. PubMed ID: 9447212 [No Abstract] [Full Text] [Related]
37. Thrombolysis for acute ischemic stroke in the primary antiphospholipid syndrome. Julkunen H; Hedman C; Kauppi M J Rheumatol; 1997 Jan; 24(1):181-3. PubMed ID: 9002032 [TBL] [Abstract][Full Text] [Related]
38. Impact of regional pre-hospital emergency medical services in treatment of patients with acute ischemic stroke. Sozener CB; Barsan WG Ann N Y Acad Sci; 2012 Sep; 1268():51-6. PubMed ID: 22994221 [TBL] [Abstract][Full Text] [Related]
39. [Thrombolysis in acute stroke with tissue plasminogen activator]. Willig V; Hacke W Dtsch Med Wochenschr; 1996 Mar; 121(13):A8-A10. PubMed ID: 8681730 [No Abstract] [Full Text] [Related]
40. Intravenous thrombolytic therapy for acute ischemic stroke. Weighing the risks and benefits of tissue plasminogen activator. Koller RL; Anderson DC Postgrad Med; 1998 Apr; 103(4):221-4, 229-31. PubMed ID: 9553597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]